In addition, defects in glucose uptake caused by NEK1 depletion stimulate RIPK1 activation, while inhibition of RIPK1 restores BBB damage, neuroinflammation, and accumulation of misfolded proteins, suggesting ALS may be treated by blocking RIPK1 activation.534. The gene discussed is RIPK1; the disease is amyotrophic lateral sclerosis.